In 2015, the world adopted 17 sustainable development goals (SDGs) with 169 targets to be achieved by 2030. […]

AbstractObjectiveTo describe the development and validation of a novel patient reported outcome measure for symptom burden from long […]

The government’s Antivirals Taskforce has procured more antivirals per population than any other country in Europe, with over […]

Brophy emphasises the dangers of making decisions based on a single prematurely terminated trial.1 The molnupiravir trials have […]

The data on which the approval of molnupiravir was based in Japan1 and the data reported by Bernal […]

Brophy’s editorial on Merck’s Move-Out trial of molnupiravir raises important concerns about the approval of molnupiravir to treat […]

Using a different covid-19 vaccine for the third “booster” dose than was used for the initial two doses […]

The NHS has relaxed infection prevention and control (IPC) requirements for hospitals and GP practices that were introduced […]

Covid-19 cases in the US rose by 43% over the past two weeks, with especially high rates seen […]

The prevalence of sexually transmitted diseases (STDs) and deaths from drug overdoses increased in the US over the […]